International Bioscience Commercialization Consortium is categorized under Associations in Phoenix, AZ and active since 2010.
International Bioscience Commercialization Consortium was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Associations business, which does work in the B2B market, and is classified as a Associations, under code number 813910 by the NAICS.
If you are seeking more information, feel free to contact James Walbom at the company’s single location by writing to 445 North 5th St # 600, Phoenix, Arizona AZ 85004 or by phoning (602) 343-8838. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | International Bioscience Commercialization Consortium |
| Contact Person: | James Walbom |
| Address: | 445 North 5th St # 600, Phoenix, Arizona 85004 |
| Phone Number: | (602) 343-8838 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Associations |
| SIC Code: | 8611 |
| NAICS Code: | 813910 |
| Share This Business: |
International Bioscience Commercialization Consortium was started in 2010 to provide professional Associations under the SIC code 8611 and NAICS code 813910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact James Walbom for inquiries that concern International Bioscience Commercialization Consortium by calling the company number (602) 343-8838, as your correspondence is most welcome. Additionally, the physical location of the single location of International Bioscience Commercialization Consortium can be found at the coordinates 33.451851,-112.067291 as well as the street address 445 North 5th St # 600 in Phoenix, Arizona 85004.
For its online presence, you may visit International Bioscience Commercialization Consortium’s website at and engage with its social media outlets through on Twitter and on Facebook.